1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) is sponsored by National Institute on Aging (NIA) / National Institute of Nursing Research (NINR).
This Notice of Funding Opportunity (NOFO) invites R01 applications proposing research on palliative care across the lifespan for persons with serious illnesses and/or their care partners, relevant to the missions of participating NIH Institutes, Centers, and Offices. This includes projects focused on palliative care access, use, and quality.
Applications may propose non-clinical trial palliative care research, such as health services research, methodologic research, natural experiments, or observational studies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the opportunity page linked on this listing to help you evaluate fit faster.
Opportunity Listing - Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) Simpler. Grants. gov uses Login.
gov to verify your identity and manage your account securely. You don't need a separate username or password for this site. Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) Agency: National Institutes of Health Assistance Listings: 93.
853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders 93. 865 -- Child Health and Human Development Extramural Research 93. 361 -- Nursing Research 93.
393 -- Cancer Cause and Prevention Research 93. 242 -- Mental Health Research Grants 93. 307 -- Minority Health and Health Disparities Research Last Updated: October 14, 2026 View version history on Grants.
gov The purpose of this Notice of Funding Opportunity (NOFO) is to invite R01 applications proposing research on palliative care across the lifespan for persons with serious illnesses and/or their care partners relevant to the missions of participating NIH Institutes, Centers, and Offices (ICOs), including projects focused on palliative care access, use, and quality.
Applications may propose hypothesis-driven, milestone-defined palliative care traditional efficacy (Stage II), real-world efficacy (Stage III), effectiveness (Stage IV), and/or dissemination and implementation (Stage V) clinical trials in alignment with the NIH Stage Model (Stages II-V) and relevant Institute or Center policies.
Applications may propose non-clinical trial palliative care research, such as health services research, methodologic research, natural experiments, or observational studies. Recipients will become members of the research community facilitated by the NIH-funded Advancing the Science of Palliative Care Across the Lifespan (ASCENT) Consortium.
NOTE : This NOFO is not appropriate for applications proposing new intervention generation, refinement, modification, adaptation, and/or pilot testing (Stage I of the NIH Stage Model) clinical trial research. The intervention(s) to be tested must be in a developed and testable form, with Stage I activities already completed and demonstrated.
Nonprofits non-higher education with 501(c)(3) Nonprofits non-higher education without 501(c)(3) Other Native American tribal organizations Private institutions of higher education Public and state institutions of higher education Independent school districts City or township governments Special district governments Public and Indian housing authorities Federally recognized Native American tribal governments For-profit organizations other than small businesses Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Grantor contact information NIA Palliative Care Research NIAPalliativeCareResearch@nih. gov NIAPalliativeCareResearch@nih. gov NIAPalliativeCareResearch@nih.
gov File name Description Last updated PAR-27-090-Full-Announcement. html PAR-27-090-Full-Announcement. html Oct 14, 2026 06:50 PM UTC Link to additional information Closing: November 5, 2029 Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: Investigators with an interest in palliative care research. Specific eligibility varies by the linked funding opportunity. Recipients will become members of the research community facilitated by the NIH-funded Advancing the Science of Palliative Care Across the Lifespan (ASCENT) Consortium. Confirm the full requirements in the official notice before applying.
Applications for Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) are due November 6, 2029. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) is funded by National Institute on Aging (NIA) / National Institute of Nursing Research (NINR). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The National Institute on Aging's FY 2026 AD/ADRD portfolio consolidates the dementia research infrastructure layer — NCRAD, NACC, the new AI and Technology Collaboratory Coordinating Center — into a small number of large, often single-source cooperative agreements. The $113M new-research increment goes elsewhere. For investigators submitting in FY 2026, the structural change matters more than the headline dollar number.
Read articleSeven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read article